EcoDrugPlus

Integrin, Beta 5

Ensembl ID : ENSEEEG00000004486
Gene Symbol: ITGB5
4 Cross references
211 Possible Orthologues:

Integrin, Beta 7

Ensembl ID : ENSEEEG00000013445
Gene Symbol: ITGB7
3 Cross references
149 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSEEEG00000019799
Gene Symbol: IRAK4
4 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSEEEG00000018742
Gene Symbol: IDH1
4 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSEEEG00000016730
Gene Symbol: IDH2
4 Cross references
250 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSEEEG00000004878
Gene Symbol: KEAP1B
4 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSEEEG00000019294
Gene Symbol: KDR
4 Cross references
198 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSEEEG00000010564
Gene Symbol: KIF11
2 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSEEEG00000002687
Gene Symbol: KIF5B
4 Cross references
275 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSEEEG00000002131
Gene Symbol: KIF5B
4 Cross references
274 Possible Orthologues:

Lectin, Galactoside Binding Soluble 3a

Ensembl ID : ENSEEEG00000006961
Gene Symbol: LGALS3A
4 Cross references
220 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSEEEG00000009489
Gene Symbol: LTA4H
4 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).